Tue, February 1, 2011
Mon, January 31, 2011
Sun, January 30, 2011
Fri, January 28, 2011
Thu, January 27, 2011
Wed, January 26, 2011
Tue, January 25, 2011
Mon, January 24, 2011
Sun, January 23, 2011
Sat, January 22, 2011
Fri, January 21, 2011
Thu, January 20, 2011
Wed, January 19, 2011
Tue, January 18, 2011
Mon, January 17, 2011
Fri, January 14, 2011
[ Fri, Jan 14th 2011 ] - Market Wire
ICON Acquires Oxford Outcomes
Thu, January 13, 2011
Wed, January 12, 2011
Tue, January 11, 2011
Mon, January 10, 2011
[ Mon, Jan 10th 2011 ] - Market Wire
Teleflex Acquires VasoNova Inc.
[ Mon, Jan 10th 2011 ] - Market Wire
30 A.M. ET
Sun, January 9, 2011
Fri, January 7, 2011
Thu, January 6, 2011
Wed, January 5, 2011

Illumina to Open Latin America Office


//health-fitness.news-articles.net/content/2011/01/18/illumina-to-open-latin-america-office.html
Published in Health and Fitness on Tuesday, January 18th 2011 at 16:40 GMT by Market Wire   Print publication without navigation


SAN DIEGO--([ BUSINESS WIRE ])--Illumina, Inc. (NASDAQ:ILMN) announced today at the 19th Plant and Animal Genome Conference that the company will open an office in Sao Paolo, Brazil, to focus on developing business opportunities across Latin America. The office will open on February 1, 2011.

"This new office will strengthen our commitment to the region by making it easier for researchers to access our innovative technology and proven expertise."

aWea™re excited about the potential for expanding our business in Latin America, where Illuminaa™s technology is already facilitating important genetic research in both agriculture and human health,a said Matt Posard, Vice President of Global Sales at Illumina. aThis new office will strengthen our commitment to the region by making it easier for researchers to access our innovative technology and proven expertise.a

For more information, please contact Roberto Braga, General Manager, Latin America Operations, Illumina, at [ rbraga@illumina.com ].

About Illumina

Illumina ([ http://www.illumina.com ]) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.


Publication Contributing Sources